Waters Stock Price, News & Analysis (NYSE:WAT)

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its board has authorized a share repurchase program on Tuesday, April 24th 2018, which permits the company to buyback $3,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 18.2% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board believes its shares are undervalued.

Waters Co. (NYSE:WAT) issued its quarterly earnings results on Tuesday, July, 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.11 by $0.03. The medical instruments supplier earned $599.20 million during the quarter, compared to the consensus estimate of $601.46 million. Waters had a net margin of 24.09% and a return on equity of 50.64%. The business's revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the company posted $1.95 earnings per share. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Waters.

Waters will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Waters issued an update on its FY19 earnings guidance on Tuesday, July, 30th. The company provided earnings per share (EPS) guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus estimate of $9.08.

10 brokerages have issued twelve-month price targets for Waters' stock. Their forecasts range from $177.00 to $260.00. On average, they anticipate Waters' stock price to reach $207.40 in the next twelve months. This suggests that the stock has a possible downside of 3.2%. View Analyst Price Targets for Waters.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

News stories about WAT stock have been trending negative on Monday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Waters earned a news sentiment score of -2.8 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Waters.

Waters saw a increase in short interest in the month of September. As of September 15th, there was short interest totalling 5,380,000 shares, an increase of 6.7% from the August 15th total of 5,040,000 shares. Based on an average trading volume of 565,300 shares, the days-to-cover ratio is presently 9.5 days. Currently, 8.1% of the company's stock are sold short. View Waters' Current Options Chain.

Some companies that are related to Waters include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Avantor (AVTR), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Eyepoint Pharmaceuticals (EYPT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Home Depot (HD), Alibaba Group (BABA), Honeywell International (HON), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO), NVIDIA (NVDA), Procter & Gamble (PG) and QUALCOMM (QCOM).

Waters' stock is owned by many different of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.03%), Gulf International Bank UK Ltd (0.03%), Pacer Advisors Inc. (0.01%), Crossmark Global Holdings Inc. (0.01%), Diversified Trust Co (0.00%) and First Hawaiian Bank (0.00%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Douglass Winthrop Advisors LLC, Crossmark Global Holdings Inc., Gulf International Bank UK Ltd, CLARET ASSET MANAGEMENT Corp and Rockland Trust Co.. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, Elizabeth B Rae, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

WAT stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Pacer Advisors Inc., First Hawaiian Bank and Diversified Trust Co. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $214.17.

Waters has a market capitalization of $14.30 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]